These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1939 related articles for article (PubMed ID: 7726138)

  • 1. KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas.
    Gloghini A; Rizzo A; Zanette I; Canal B; Rupolo G; Bassi P; Carbone A
    Am J Clin Pathol; 1995 Apr; 103(4):425-31. PubMed ID: 7726138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases.
    Carbone A; Gloghini A; Volpe R; Pinto A
    Hum Pathol; 1993 Aug; 24(8):886-96. PubMed ID: 7690736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.
    Falini B; Flenghi L; Pileri S; Gambacorta M; Bigerna B; Durkop H; Eitelbach F; Thiele J; Pacini R; Cavaliere A
    Am J Pathol; 1993 May; 142(5):1359-72. PubMed ID: 7684194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD68 reactivity of non-macrophage derived tumours in cytological specimens.
    Doussis IA; Gatter KC; Mason DY
    J Clin Pathol; 1993 Apr; 46(4):334-6. PubMed ID: 7684403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry.
    Carbone A; Gloghini A; Colombatti A; Castronovo V; Ménard S
    Hum Pathol; 1995 May; 26(5):541-6. PubMed ID: 7750938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.
    Kunisch E; Fuhrmann R; Roth A; Winter R; Lungershausen W; Kinne RW
    Ann Rheum Dis; 2004 Jul; 63(7):774-84. PubMed ID: 15194571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.
    Warnke RA; Pulford KA; Pallesen G; Ralfkiaer E; Brown DC; Gatter KC; Mason DY
    Am J Pathol; 1989 Dec; 135(6):1089-95. PubMed ID: 2688430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KP1 (CD68) expression in benign neural tumours. Further evidence of its low specificity as a histiocytic/myeloid marker.
    Dei Tos AP; Doglioni C; Laurino L; Fletcher CD
    Histopathology; 1993 Aug; 23(2):185-7. PubMed ID: 8406391
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of interstitial increase in macrophages, characteristic of acute interstitial rejection, in routinely processed renal allograft biopsies using the monoclonal antibody KP1.
    Dooper IM; Bogman MJ; Hoitsma AJ; Maass CN; Assmann KJ; Koene RA
    Transpl Int; 1992 Sep; 5(4):209-13. PubMed ID: 1384532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas.
    Carbone A; Gloghini A; Zanette I; Canal B; Volpe R
    Am J Clin Pathol; 1993 Mar; 99(3):289-97. PubMed ID: 8383422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.
    Cassidy M; Loftus B; Whelan A; Sabt B; Hickey D; Henry K; Leader M
    Virchows Arch; 1994; 424(6):635-40. PubMed ID: 7519954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of macrophage-associated antigens (CD68 and Ki-M1P) by Schwann cells in reactive and neoplastic neural tissue. Light- and electron-microscopic findings.
    Kaiserling E; Xiao JC; Ruck P; Horny HP
    Mod Pathol; 1993 Jul; 6(4):463-8. PubMed ID: 8415593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
    Binder SW; Said JW; Shintaku IP; Pinkus GS
    Am J Clin Pathol; 1992 Jun; 97(6):759-63. PubMed ID: 1317667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hematopoietic breast tumors.
    Lin Y; Govindan R; Hess JL
    Am J Clin Pathol; 1997 Feb; 107(2):177-86. PubMed ID: 9024066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
    Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
    Wobser M; Roth S; Reinartz T; Rosenwald A; Goebeler M; Geissinger E
    Br J Dermatol; 2015 Jun; 172(6):1573-1580. PubMed ID: 25524664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.